In the Boardroom
Refine Search
Biotechnology
Canadian clinical-stage oncology company ProNAi Therapeutics has appointed Barbara Klencke as chief development officer. 23 June 2015
Biotechnology
German clinical stage biopharma company Affimed NV has established operations in the USA. 23 June 2015
Biotechnology
Clinical-stage nanomedicines company BIND Therapeutics has appointed Andrew Hirsch as president and chief executive. 23 June 2015
Pharmaceutical
American pharma company Pozen has appointed Mark Glickman as chief commercial officer, Eric Trachtenberg as deputy general counsel, and Jennifer Armstrong as executive vice president of human resources and administration. 22 June 2015
Biotechnology
Switzerland-based ADC Therapeutics has appointed Chris Martin as its chief executive. 22 June 2015
Pharmaceutical
Anglo-Swedish drug major AstraZeneca has appointed Pam Cheng as executive vice president of operations and IT. 16 June 2015
Pharmaceutical
Briggs Morrison, former vice president global medicines development and chief medical officer at AstraZeneca, is joining privately-held oncology company Syndax Pharmaceuticals as chief executive officer. 16 June 2015
Biotechnology
Regenerative medicine company Pasticell has recruited Aaron Chuang as chief scientific officer. 15 June 2015
Pharmaceutical
Canada-based pharma company Valeant has appointed Robert Rosiello as chief financial officer. 11 June 2015
Pharmaceutical
Privately-held biopharma company Turing Pharmaceuticals has appointed Eliseo Oreste Salinas as president of research and development. 2 June 2015
Pharmaceutical
Japanese drug major Eisai has appointed Ivor Macleod as senior vice president, chief financial officer and chief compliance officer of its US pharma subsidiary. 2 June 2015
Biotechnology
Independent US biotech company Amgen has appointed Corinne Le Goff as senior vice president and head of the European region. 1 June 2015
Pharmaceutical
Ronald Martell has been appointed to the position of executive chairman of KaloBios Pharmaceuticals. 29 May 2015
Pharmaceutical
Paolo Paoletti has been appointed as executive chairman of multiple myeloma specialist Kesios Therapeutics. 29 May 2015
Pharmaceutical
Joseph Bedford appointed corporate vice president of global strategic marketing at Huntingdon/Harlan
Huntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president of global strategic marketing. 27 May 2015
Pharmaceutical
French drug major Sanofi has appointed Suresh Kumar as a new member of the executive committee and as executive vice president of external affairs. 26 May 2015
Pharmaceutical
Clinical-stage infection-focused biopharma company Nabriva Therapeutics has appointed Elyse Seltzer as chief medical officer. 22 May 2015
Pharmaceutical
French biopharma company Poxel has appointed Noah Beeman as executive vice president of business development and president of US operation to spearhead the company’s expanding presence in the USA. 21 May 2015
Pharmaceutical
US specialty pharma company CutisPharma has appointed Neal Muni as chief executive. 19 May 2015
Biotechnology
UK biotech company Calchan has appointed Zahid Ali as chief scientific officer. 14 May 2015
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze